Baxter International (NYSE:BAX) Issues FY24 Earnings Guidance

Baxter International (NYSE:BAXGet Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $2.88-$2.98 for the period, compared to the consensus EPS estimate of $2.90. The company issued revenue guidance of $15.1 billion, compared to the consensus revenue estimate of $15.10 billion. Baxter International also updated its Q2 guidance to $0.65-$0.67 EPS.

Baxter International Stock Performance

Baxter International stock traded down $0.02 during mid-day trading on Friday, reaching $36.89. The company’s stock had a trading volume of 6,246,789 shares, compared to its average volume of 3,358,723. The firm’s fifty day moving average price is $41.53 and its two-hundred day moving average price is $38.75. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.04 and a current ratio of 1.48. Baxter International has a 12-month low of $31.01 and a 12-month high of $50.21. The company has a market capitalization of $18.73 billion, a P/E ratio of 7.09, a PEG ratio of 1.98 and a beta of 0.64.

Baxter International (NYSE:BAXGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.04. The company had revenue of $3.59 billion during the quarter, compared to analysts’ expectations of $3.55 billion. Baxter International had a return on equity of 18.97% and a net margin of 17.79%. The firm’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.59 earnings per share. Sell-side analysts predict that Baxter International will post 2.9 EPS for the current fiscal year.

Baxter International Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 1st were issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 3.14%. The ex-dividend date of this dividend was Thursday, February 29th. Baxter International’s payout ratio is 22.31%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Barclays upped their target price on shares of Baxter International from $52.00 to $54.00 and gave the stock an overweight rating in a report on Monday, February 12th. Bank of America increased their price objective on Baxter International from $42.00 to $45.00 and gave the stock a neutral rating in a research report on Tuesday, March 5th. StockNews.com upgraded Baxter International from a hold rating to a buy rating in a research report on Friday, January 19th. JPMorgan Chase & Co. raised their price target on Baxter International from $38.00 to $44.00 and gave the company a neutral rating in a report on Friday, February 9th. Finally, Citigroup boosted their price objective on Baxter International from $41.00 to $44.00 and gave the stock a neutral rating in a report on Wednesday, April 3rd. Seven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Baxter International presently has an average rating of Hold and an average target price of $46.30.

Read Our Latest Stock Analysis on Baxter International

About Baxter International

(Get Free Report)

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

Featured Articles

Earnings History and Estimates for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.